Delivery Order SPE2DR25D2011-SPE2DR26FADGH
- Not listed
- The Defense Logistics Agency awarded a $2,603.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is an unset-aside delivery order, awarded through competitive procurement, demonstrating AmerisourceBergen's...
- The Defense Logistics Agency awarded a $31,632.15 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. This competitively awarded, firm fixed-price delivery order was established on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract involves no set-aside designation, reflecting AmerisourceBergen's ability to compete in open federal procurement. Performance will be...
- The Defense Logistics Agency awarded a $15,001.90 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,524.72 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $45,894.09 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on August 18, 2025, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by August 19, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $37,535.24 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product for cholesterol management. This firm fixed-price delivery order, issued on September 9, 2025, with completion targeted for September 10, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $4,021.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick medication, with an ultimate completion date of October 22, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under the company's larger pharmaceutical supply relationship with DLA. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,795.80 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick, a specialty pharmaceutical product used in cardiovascular disease treatment. This firm fixed-price delivery order, issued on September 22, 2025, represents a non-competitive, non-set-aside procurement executed under the company's existing DLA contract vehicle. The place of performance is AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.24 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, a specialty pharmaceutical product used in cardiovascular disease management. This firm fixed-price, competitively awarded delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the awardee and place of performance for this...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease treatment. This competitively awarded, non-set-aside delivery order carries a ceiling value of $7,071.38 and is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025. The award was issued on November 4, 2025, with performance taking place at AmerisourceBergen's corporate...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADGHDelivery Order
The Defense Logistics Agency awarded a $45,293.97 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick, a pharmaceutical product used in cardiovascular disease treatment. This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a non-competitive award to the established vendor. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract serves as the vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The IDC represents a strategic sourcing arrangement that enables DLA to procure a diverse range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains through a single, flexible contract mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.3k | 11/3/25 |